 Home > Active Pharmaceutical Ingredients > Other Chemical Drugs > N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine for Sale > Jinlan 98+ EP/BP/USP Tucatinib

Jinlan 98+ EP/BP/USP Tucatinib

Name: Jinlan 98+ EP/BP/USP Tucatinib
Brand: Jinlan
SKU: pr26012240674
Price: 128 USD
Availability: InStock

1 Inquiries

Unit Price: Get Latest Price 

CAS No.:

937263-43-9

Grade:

medical grade

Content:

98%

Port:

Shanghai/Ningbo/Qingdao

Brand:

Jinlan

Packaging:

25kg/Cardboard Drum

Price valid (until):

2026-03-01

Contact Supplier

 Chat Now

Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd

Company Type:

Trader

Location:

China

Qualification:

Main Products:

Peptides,API,Intermediate

 Visit Store

Product Description
Seller Information
Inquiry History

Description

Product Detail

Tucatinib (937263-43-9)

Basic Product Description

CAS Number: 937263-43-9

Chemical Name: 2-[4-[[(3R)-3,4-Dihydro-3-hydroxy-2H-pyran-6-yl]methoxy]phenyl]-5-fluoro-3,4-dihydro-4-oxoquinazoline

Molecular Formula: C₁₈H₁₅FN₂O₅

Molecular Weight: 358.32 g/mol

Synonyms: Tukysa®, ONT-380

Related Categories: Selective Human Epidermal Growth Factor Receptor 2 (HER2) Tyrosine Kinase Inhibitor (TKI), Oral Small Molecule TKI, HER2-Positive Breast Cancer Therapeutic

Key Highlight: A potent and highly selective oral HER2 TKI with no significant inhibition of EGFR, minimizing EGFR-related toxicities; indicated in combination with trastuzumab and capecitabine for the treatment of advanced or metastatic HER2-positive breast cancer, including patients with central nervous system (CNS) metastases and those who have received prior anti-HER2 therapy; exerts anti-tumor effects by selectively blocking aberrant HER2 signaling pathways to inhibit tumor cell proliferation, migration and metastasis.

Basic Info

Product Name:

N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine

Other Name:

4,6-Quinazolinediamine,N6-(4,5-dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-;N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine;ARRY 380;ONT 380;Tucatinib;Tukysa

CAS No.:

937263-43-9

Molecular Formula:

C26H24N8O2

InChIKeys:

InChIKey=SDEAXTCZPQIFQM-UHFFFAOYSA-N

Molecular Weight:

480.52116

Exact Mass:

480.52

UNII:

234248D0HH

NCI Thesaurus Code:

C77896

ATC Code:

L01|L - Antineoplastic and immunomodulating agents

Categories:

Other Chemical Drugs

Characteristics

PSA:

111

XLogP3:

Density:

1.4±0.1 g/cm3

Melting Point:

230

Refractive Index:

1.729

See More N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine Properties 

Hazard Identification

Classification of the substance or mixture

no data available

GHS label elements, including precautionary statements

Precautionary statement(s)
Pictogram(s)	no data available
Signal word	no data available
Hazard statement(s)	no data available
Prevention	no data available
Response	no data available
Storage	no data available
Disposal	no data available

Other hazards which do not result in classification

no data available

Handling and Storage

Precautions for safe handling

Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.

Conditions for safe storage, including any incompatibilities

Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.

See More N6-(4,5-Dihydro-4,4-dimethyl-2-oxazolyl)-N4-[3-methyl-4-([1,2,4]triazolo[1,5-a]pyridin-7-yloxy)phenyl]-4,6-quinazolinediamine Safety Data Sheet 

Seller Information

Business Type:
Trader

Main Products:
Peptides,API,Intermediate

Location:
Room 606, Building 1, Fu Yi Commercial Center, Shangcheng District, Hangzhou City, Zhejiang Province - 1

Payment Terms:
100% TT in advance

Average lead Time:
275

Total Annual Revenue:
$1 million-$2.5 million

Total Employees:
51-100

Year of Establishment:
2020

Hangzhou Jinlan Pharm-Drugs Technology Co., Ltd (with its export company Hangzhou Royall Import & Export Co.,Ltd.) is located in Hangzhou, Zhejiang Province. Neighboring Ningbo port, Shanghai port, Hangzhou Xiaoshan Int' l Airport and Shanghai Pudong Int' l Airport, the transportation and production environment are excellent. JINLAN PHARMA mainly business includes: 1) API, Pharmaceutical Intermediates, CMO, CRO, CDMO and so on. 2) Pharmaceutical Equipment such as: Distilled Water Machinery, Mixer, Sterilizer and so on.

JINLAN PHARM focus on:

■ Contrast Agent

■ Anti-COVID APIs

■ Respiratory System APIs

■ Anti-tumor & Anti-Cancer APIs

■ Anti-Diabetes APIs

■ Anti-HCV & Anti-HBV APIs

■ Anti-HIV APIs

■ Peptides

■ Pharmaceutical Intermediates

■ CMO, CRO, CDMO

Inquiry History

1 Inquiries

Country	Product	Purchase Quantity	Date Posted
South Korea	Tucatinib 937263-43-9	10 G	Sep 17, 2025

Post an enquiry for this product

More Choices Find All Products for Sale 

Product Name	Grade / Content	Supplier Name	Details
API Tucatinib	Pharmaceutical Grade/99	Hangzhou Hyper Chemicals Limited	Inquiry
Factory price Tucatinib 937263-43-9	/	SHANDONG LOOK CHEMICAL CO.,LTD	Inquiry
6-diaMine	/99.00	HANGZHOU LEAP CHEM CO., LTD.	Inquiry
high quality Irbinitinib 99% transparent liquid KANBEI	Industrial Grade/99	Henan Lihao Chem Plant Limited	Inquiry
Irbinitinib.	Chemical Grade/99	Shaanxi Dideu Medichem Co. Ltd	Inquiry